Stent Tek, a medical device company that is developing a minimally invasive catheter system for dialysis patients, announced today it has successfully closed a Series A funding round with investments from two institutional investors.
Teva’s Austedo is now the first and only therapy approved in the US to treat both tardive dyskinesia and chorea associated with Huntington’s disease.
Nemaura Medical Inc. (NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless adhesive skin-patch for adjunctive use by diabetics as a non-invasive and needle-free continuous glucose monitoring (CGM) system announced today that it has completed development of a medical grade app prepared and verified in accordance with ISO13485 quality systems and the appropriate medical devices directives, and designed to be used with the sugarBEAT® device or with glucose meters and strips to display glucose levels on users android mobile devices.
The vexing problem of how to increase the loyalty of clients has always been troublesome to people specializing in foreign trade. Salesmen often find that their clients may say goodbye to them and end their business relationship, simply to start a new one and on other occasions, their clients disappear without any notice. In order to mitigate issues such as these, we should know what causes this behavior and how to remedy the problem.
With economic development and the ongoing medical reform, people are becoming more and more concerned about their health care and the diagnostic equipment market in China is growing at a compound annual rate of about 10%.
MicroPort Orthopedics has launched its new Procotyl Prime Acetabular Cup System, following 510(k) clearance from the US Food and Drug Administration in June.
An anti-inflammatory drug has significantly lowered the risk of recurrent heart attacks, strokes and cardiovascular death, all without reducing cholesterol, according to research recently published in the New England Journal of Medicine and shared at a meeting of the European Society of Cardiology.
A robotic exoskeleton for the treatment of crouch (or flexed-knee) gait in children with cerebral palsy has been developed by US researchers from the Rehabilitation Medicine department of the NIH Clinical Centre.
The European Commission has licensed EUSA Pharma’s Fotivda for the management of adult patients with advanced kidney cancer across the European Union as well as Norway and Iceland.
MedGenomeGenomics research and diagnostics company MedGenome said today that it closed a $30 million Series C round led by Sequoia India and Sofina. Zodius Capital, the co-founder & former CEO of Infosys, Kris Gopalakrishnan, and former Cognizant CEO Lakshmi Narayanan also participated in the round.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.